- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Resistance in Lung Cancer
Deadline: 15 March 2027
Pathogenesis and Treatment Strategies in Multiple Myeloma: From Basic Research to Real Life: 2nd Edition
Deadline: 31 December 2026
Innovations in Cutaneous Oncology and Dermatologic Surgery: Translating Mechanisms into Practice
Deadline: 31 December 2026
Advancing Therapeutic Strategies for Neuroendocrine Tumors: Towards Personalized and Multidisciplinary Care
Deadline: 31 December 2026
Minimally Invasive Surgery in Gynecologic Cancers
Deadline: 31 December 2026
Hematological Malignancies: From Translational Discoveries to Clinical Trends
Deadline: 20 December 2026
Clinical Treatment and Prognostic Factors of Urologic Cancer
Deadline: 15 December 2026
Advances in Hormone-Based Breast Cancer Treatment
Deadline: 5 December 2026
New Findings in Targeting Cancer Proteins (Second Edition)
Deadline: 30 November 2026
Advances in the Management of Pelvic Tumors: 2nd Edition
Deadline: 30 November 2026
Intraoperative Radiotherapy in Cancer Treatment
Deadline: 30 November 2026
Innovations and Current Evidence in Radiotherapy for Urological Cancers
Deadline: 30 November 2026
of 68

